Arnab Das
2A &2B Raja S. C. Mullick Road
Kolkata, WB 700032, India
Kolkata, WB 700032, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Exploring neutral backbones in phosphorodiamidate morpholino oligomers: synthesis and biophysical properties.
Journal: Chemical communications (Cambridge, England)
Published: June 25, 2026
Real-World Comparison of Biosimilar Ranibizumab (Ranieyes) and Innovator Ranibizumab (Lucentis/Accentrix) Across Multiple Retinal Vascular Diseases (The BRIO Study).
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 22, 2026
Mapping Tridosha Prakriti to Anthropometric Somatotype and Body Composition: A Cross-sectional Study.
Journal: Advances in mind-body medicine
Published: March 10, 2026
Clinical evaluation of faricimab in real-world neovascular age-related macular degeneration in India: a multicenter observational study.
Journal: BMC ophthalmology
Published: December 24, 2025
Biosimilar anti-vascular endothelial growth factor agents: Clinical outcomes, safety, and cost-effectiveness in India.
Journal: Indian journal of ophthalmology
Published: December 15, 2025
Mapping Cardiorespiratory and Metabolic Demands across Fast and Slow Surya Namaskar Sequences.
Journal: International journal of yoga
Published: August 27, 2025
Short-term 6° head-down tilt bed rest simulating microgravity ameliorates blood pressure and heart rate variability: A quasi-experimental study on healthy adults.
Journal: Life sciences in space research
Published: July 16, 2025
Immediate effect of Suryanamaskar on cardiorespiratory functions and cognitive performance: A quasi-experimental study on young adult females.
Journal: Journal of Ayurveda and integrative medicine
Published: April 05, 2025
Degradation of antibiotics by anodic oxidation (AO) and electro Fenton (EF) process - a comparative review.
Journal: Journal of environmental management
Published: March 11, 2025
CompaRative Safety Analysis of Innovator and BioSimilar Ranibizumab in Chorioretinal Vascular Diseases - The CRsIBS Study.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: January 03, 2025
Transitioning from Aflibercept to Biosimilar Ranibizumab in Diabetic Macular Edema (DME): (The TRANSFORM-DME Trial) a Multicenter Observational Study.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: October 25, 2024
Last Updated: 09/26/2026